About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Genotropin Study Assessing Use of Injection Pen

NCT00965484·25 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Pfizer

Age

8–18

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Age 8-18 years
Using genotropin pen for at least 3 months prior to study enrollment
Compliance with genotropin treatment

You may not be if

Medical conditions that can affect participation in study
Insufficient command of English language to understand questionnaire
Using other growth hormone device and not Genotropin pen

The record

StatusCompleted

PhasePhase 3

Taking part136

StartedOct 2009

UpdatedJan 28, 2011

Conditions

Growth Hormone Deficiency Idiopathic Short Stature

Where25

Pfizer Investigational Site
Los Angeles, California, United States
Pfizer Investigational Site
San Diego, California, United States
Pfizer Investigational Site
Greenwood Village, Colorado, United States

Clareo Health | Genotropin Study Assessing Use of Injection Pen